Shrinking budgets have created a "pay-to-play" system where patients pay for clinical trials. This problem exploits families and ruins data accuracy. The solution is to ban these charges to protect the ethical foundation of medicine. The benefit is a fair research process that ensures life-saving treatments are developed based on rigorous science and high-quality evidence, rather than a participant’s ability to pay for access.
